Citadel Advisors
GWPH

Citadel Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Citadel Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-99,400
Closed -$21.6M – 14960
2021
Q1 		$21.6M Sell
99,400
-7,300
-7% -$1.37M 0.01% 1870
2020
Q4 		$12.3M Buy
106,700
+19,400
+22% +$2.17M ﹤0.01% 2377
2020
Q3 		$8.5M Sell
87,300
-18,400
-17% -$2.12M ﹤0.01% 2484
2020
Q2 		$13M Sell
105,700
-10,000
-9% -$1.13M ﹤0.01% 1940
2020
Q1 		$10.1M Buy
115,700
+10,100
+10% +$1.07M ﹤0.01% 1838
2019
Q4 		$11M Sell
105,600
-67,500
-39% -$7.57M ﹤0.01% 2094
2019
Q3 		$19.9M Buy
173,100
+84,700
+96% +$12.9M 0.01% 1473
2019
Q2 		$15.2M Sell
88,400
-45,900
-34% -$7.94M 0.01% 1695
2019
Q1 		$22.6M Sell
134,300
-21,500
-14% -$3.2M 0.01% 1230
2018
Q4 		$15.2M Buy
155,800
+5,000
+3% +$656K 0.01% 1461
2018
Q3 		$26M Buy
150,800
+54,600
+57% +$7.87M 0.01% 1186
2018
Q2 		$13.4M Buy
96,200
+32,500
+51% +$4.62M 0.01% 1655
2018
Q1 		$7.18M Buy
63,700
+20,300
+47% +$2.55M ﹤0.01% 2054
2017
Q4 		$5.73M Sell
43,400
-18,900
-30% -$2.22M ﹤0.01% 2327
2017
Q3 		$6.32M Buy
62,300
+31,000
+99% +$3.32M ﹤0.01% 2049
2017
Q2 		$3.14M Sell
31,300
-14,100
-31% -$1.52M ﹤0.01% 2608
2017
Q1 		$5.49M Sell
45,400
-11,900
-21% -$1.46M 0.01% 1948
2016
Q4 		$6.4M Sell
57,300
-33,300
-37% -$4.01M 0.01% 1739
2016
Q3 		$12M Buy
90,600
+27,800
+44% +$2.66M 0.01% 1216
2016
Q2 		$5.75M Buy
+62,800
New +$5.29M 0.01% 1704

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Citadel Advisors's GWPH Position: Q2 2021 in Review

Citadel Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 250,719 shares — an estimated $54.4M sold.

Citadel Advisors first reported a position in GWPH in Q1 2014 and held it in 29 quarters. The position peaked at $160M in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Citadel Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Citadel Advisors sold 250,719 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $54.4M.
  • Citadel Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 29 quarters.
  • Citadel Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $160M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.